Global Melanoma Cancer Market Market Research and Forecast 2018-2023

  • ID: 4471522
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Sep 30th 2018
1 of 4

FEATURED COMPANIES

  • Ab Sciences
  • Aduro Biotech, Inc.
  • Astrazeneca
  • Celgene Corporation
  • F. Hoffman-La Roche Ltd.
  • Johnson & Johnson
  • MORE
Melanoma is a skin cancer that develops due to expose of UV rays on the skin. The disease is curable when recognized and treated in the early stages, and hence have a high success rate. Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during working, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.

However, certain factors such as high cost associated with treatment, and increasing use of generic medicine are hindering the growth of the market. Medicines such as cisplatin is a generic drug which is off patent and are manufactured by multiple companies for cancer treatment across the globe. Innovation in drug development, and subsequent technological advancements & pipeline products are expected to create significant opportunities for melanoma cancer market.

On the basis of geographical regions, the market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate in the global melanoma market owing to high prevalence of melanoma in the US and Canada along with a major market share in the region. Well-developed healthcare infrastructure and reimbursement policies are some of the major factors that are contributing towards the growth of the market in the region. Europe is also expected to have major market share during the forecast period. The UK, Germany, and France are the major countries with high prevalence of melanoma. Asia Pacific region is expected to have a considerable market growth during the forecast period owing to key contribution from China, Australia, Japan, and India. Massive pool of patients, rising disposable income and improving healthcare system are the major factors for the growth of the market in the region.

Various pharmaceutical companies are active in the melanoma market. Some of the major players include AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb and Daiichi Sankyo. The companies are focusing on product innovations, expansions, finding new markets or innovate in their core competency in order to expand individual market share. The report includes detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, market determinants, market segmentation, and company profiling.

Market Segmentation:

Global Melanoma market is bifurcated into various segments which includes-
  • Global Melanoma Market Research and Analysis, By Cancer Type
  • Global Melanoma Market Research and Analysis, By Diagnosis
  • Global Melanoma Market Research and Analysis, By Therapy
  • Global Melanoma Market Research and Analysis, By Region
The Report covers:
  • Comprehensive research methodology of Global Melanoma Market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the
  • Global Melanoma Market.
  • Insights about market determinants which are stimulating the Global Melanoma Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ab Sciences
  • Aduro Biotech, Inc.
  • Astrazeneca
  • Celgene Corporation
  • F. Hoffman-La Roche Ltd.
  • Johnson & Johnson
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
1.2.4. Exceptions

2. Market Overview and Insights
2.1. Definition
2.2. Patent Analysis
2.3. Analyst Insights & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendation
2.3.3. Conclusion
2.4. Regulation
2.4.1.1. United States
2.4.1.2. European Union
2.4.1.3. China
2.4.1.4. India

3. Market Determinant
3.1. Motivators
3.1.1. Rising Incidence of Skin-Related Disorders Such as Skin Cancer and Skin Allergies
3.1.2. Climate Change and Rising Temperature Due to Ghg Emission
3.1.3. Numerous Initiatives by Government and Private Organizations
3.1.4. Overexposure to Radiation During Certain Treatment Or Exposure to Chemicals During Working
3.1.5. Growing Number of Fda Approvals for Drugs
3.2. Restraints
3.2.1. High Cost Associated With Various Therapies
3.2.2. Side Effects Associated With the Treatment
3.3. Opportunities
3.3.1. Innovation in Drug Development, Subsequent Technological Advancements
3.3.2. Potential Market in Oceania Region
3.3.3. Drugs in Pipeline by Various Companies

4. Market Segmentation
4.1. Global Melanoma Market, by Cancer Type
4.1.1. Non-INVasive Melanoma
4.1.1.1. Superficial Spreading Melanoma
4.1.1.2. Lentigo Maligna
4.1.1.3. Acral Lentiginous Melanoma
4.1.2. INVasive Melanoma
4.1.2.1. Nodular Melanoma
4.2. Global Melanoma Market, by Diagnosis Method
4.2.1. Biopsy
4.2.2. Computed Tomography (Cat) Scan
4.2.3. Magnetic Resonance Imaging (Mri)
4.2.4. Positron Emission Tomography (Pet) Scan
4.3. Global Melanoma Market, by Therapy
4.3.1. Surgery
4.3.2. Immunotherapy
4.3.3. Targeted Therapy
4.3.4. Chemotherapy
4.3.5. Radiation Therapy

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.3. APAC
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of APAC
6.4. Rest of the World

7. Company Profiles
7.1. Ab Sciences
7.2. Abbvie Inc.
7.3. Aduro Biotech, Inc.
7.4. Amgen, Inc
7.5. Astrazeneca
7.6. Bristol-Myers Squibb Company
7.7. Castle Biosciences, Inc.
7.8. Celgene Corporation
7.9. Daiichi Sankyo Company, Limited
7.10. Enb Therapeutics, Llc
7.11. F. Hoffman-La Roche Ltd.
7.12. Incyte Corporation
7.13. Johnson & Johnson
7.14. Mela Sciences, Inc
7.15. Merck & Co., Inc.
7.16. Novartis Ag
7.17. Pierre Fabre
7.18. Scibase Holding Ab
7.19. Teleskin Doo

List of Tables:
Table 1 Global Melanoma Market Research and Analysis, by Cancer Type, 2017-2023 ($ Million)
Table 2 Non-INVasive Market Research and Analysis, 2017-2023 ($ Million)
Table 3 Global Superficial Spreading Market Research and Analysis, 2017-2023 ($ Million)
Table 4 Global Lentigo Maligna Market Research and Analysis, 2017-2023 ($ Million)
Table 5 Global Acral Lentiginous Market Research and Analysis, 2017-2023 ($ Million)
Table 6 Global INVasive Market Research and Analysis, 2017-2023 ($ Million)
Table 7 Global Nodular Market Research and Analysis, 2017-2023 ($ Million)
Table 8 Global Market, by Diagnosis Method Market Research and Analysis, 2017-2023 ($ Million)
Table 9 Global Biopsy Market Research and Analysis, 2017-2023 ($ Million)
Table 10 Global Computed Tomography (Cat) Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 11 Global Magnetic Resonance Imaging (Mri) Market Research and Analysis, 2017-2023 ($ Million)
Table 12 Global Positron Emission Tomography (Pet) Scan Market Research and Analysis, 2017-2023 ($ Million)
Table 13 Global Melanoma Market Research and Analysis, by Therapy, 2017-2023 ($ Million)
Table 14 Global Surgery Market Research and Analysis, 2017-2023 ($ Million)
Table 15 Global Immunotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 16 Global Targeted Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 17 Global Chemotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 18 Global Radiation Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 19 North America Melanoma Market Research and Analysis by Cancer Type, 2017-2023 ($ Million)
Table 20 North America Melanoma Market Research and Analysis by Diagnosis Method, 2017-2023 ($ Million)
Table 21 North America Melanoma Market Research and Analysis by Therapy, 2017-2023 ($ Million)
Table 22 North America Melanoma Market Research and Analysis by Countries, 2017-2023 ($ Million)
Table 23 Europe Melanoma Market Research and Analysis by Cancer Type, 2017-2023 ($ Million)
Table 24 Europe Melanoma Market Research and Analysis by Diagnosis Method, 2017-2023 ($ Million)
Table 25 Europe Melanoma Market Research and Analysis by Therapy, 2017-2023 ($ Million)
Table 26 Europe Melanoma Market Research and Analysis by Countries, 2017-2023 ($ Million)
Table 27 Asia Pacific Melanoma Market Research and Analysis by Cancer Type, 2017-2023 ($ Million)
Table 28 Asia Pacific Melanoma Market Research and Analysis by Diagnosis Method, 2017-2023 ($ Million)
Table 29 Asia Pacific Melanoma Market Research and Analysis by Therapy, 2017-2023 ($ Million)
Table 30 Asia Pacific Melanoma Market Research and Analysis, by Countries, 2017-2023 ($ Million)
Table 31 Rest of World Melanoma Market Research and Analysis, 2017-2023 ($ Million)

List of Figures:
Figure 1 Global Melanoma Market Share, by Cancer Type, 2017 vs 2023 (%)
Figure 2 Global Melanoma Market Share, by Diagnostic Method 2017 vs 2023 (%)
Figure 3 Global Melanoma Market Share, by Therapy 2017 vs 2023 (%)
Figure 4 Global Melanoma Market Share, by Geography, 2017 vs 2023 (%)
Figure 5 North America Melanoma Market Size, 2017-2023($ Million)
Figure 6 United States Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 7 Canada Market Melanoma Research and Analysis, 2017-2023 ($ Million)
Figure 8 Europe Market Research and Analysis, 2017-2023($ Million)
Figure 9 UK Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 10 Germany Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 11 Spain Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 12 France Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 13 Italy Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 14 ROE Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 15 Asia Pacific Market Research and Analysis, 2017-2023($ Million)
Figure 16 China Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 17 India Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 18 Japan Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 19 Rest of Asia Pacific (RoAPAC) Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Figure 20 Rest of World (Row)Melanoma Market Research and Analysis, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ab Sciences
  • Abbvie Inc.
  • Aduro Biotech, Inc.
  • Amgen, Inc
  • Astrazeneca
  • Bristol-Myers Squibb CoMPany
  • Castle Biosciences, Inc.
  • Celgene Corporation
  • Daiichi Sankyo CoMPany, Limited
  • Enb Therapeutics, Llc
  • F. Hoffman-La Roche Ltd.
  • IncyTE Corporation
  • Johnson & Johnson
  • Mela Sciences, Inc
  • Merck & Co., Inc.
  • Novartis Ag
  • Pierre Fabre
  • Scibase Holding Ab
  • Teleskin Doo
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll